INS and Other metabolic disease: Thus, it is evident that a molecular loop exists between insulin and Sestrin2 during chronic activation of mTORC1, and further studies to understand the intricate feedback that exists between insulin and Sestrin2 would give us insights to develop novel therapeutic strategies to treat metabolic disorders [25].